DarioHealth (DRIO) Tops Q3 EPS by 1c, Miss on Revenues

DarioHealth (NASDAQ: DRIO) reported Q3 EPS of ($0.30), $0.01 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $1.38 million versus the consensus estimate of $1.45 million.

Third Quarter Financial Highlights

• Record revenues of $1,375,000, increased 89% compared to the third quarter of 2016
• Sequential quarterly revenue growth of 14% over the second quarter of 2017
• 70% of quarterly revenues derived from test strips and other consumables
• More than 10,500 Dario™ Blood Glucose Monitoring System devices sold in the U.S. reaching cumulative sales of more than 43,500
• Consumable strips growth of 40% over second quarter of 2017
• Cash burn decreased by $347,000 or 13% compared to the second quarter of 2017

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
• KinderCare Learning Companies, Inc. (KLC) Misses Q2 EPS by 2c; Offers Guidance